Literature DB >> 21297158

Evolution of nuclear retinoic acid receptor alpha (RARα) phosphorylation sites. Serine gain provides fine-tuned regulation.

Eric Samarut1, Ismail Amal, Gabriel V Markov, Roland Stote, Annick Dejaegere, Vincent Laudet, Cécile Rochette-Egly.   

Abstract

The human nuclear retinoic acid (RA) receptor alpha (hRARα) is a ligand-dependent transcriptional regulator, which is controlled by a phosphorylation cascade. The cascade starts with the RA-induced phosphorylation of a serine residue located in the ligand-binding domain, S(LBD), allowing the recruitment of the cdk7/cyclin H/MAT1 subcomplex of TFIIH through the docking of cyclin H. It ends by the subsequent phosphorylation by cdk7 of an other serine located in the N-terminal domain, S(NTD). Here, we show that this cascade relies on an increase in the flexibility of the domain involved in cyclin H binding, subsequently to the phosphorylation of S(LBD). Owing to the functional importance of RARα in several vertebrate species, we investigated whether the phosphorylation cascade was conserved in zebrafish (Danio rerio), which expresses two RARα genes: RARα-A and RARα-B. We found that in zebrafish RARαs, S(LBD) is absent, whereas S(NTD) is conserved and phosphorylated. Therefore, we analyzed the pattern of conservation of the phosphorylation sites and traced back their evolution. We found that S(LBD) is most often absent outside mammalian RARα and appears late during vertebrate evolution. In contrast, S(NTD) is conserved, indicating that the phosphorylation of this functional site has been under ancient high selection constraint. This suggests that, during evolution, different regulatory circuits control RARα activity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21297158     DOI: 10.1093/molbev/msr035

Source DB:  PubMed          Journal:  Mol Biol Evol        ISSN: 0737-4038            Impact factor:   16.240


  7 in total

1.  Cullin 3 mediates SRC-3 ubiquitination and degradation to control the retinoic acid response.

Authors:  Christine Ferry; Samia Gaouar; Benoit Fischer; Marcel Boeglin; Nicodeme Paul; Eric Samarut; Aleksandr Piskunov; Gabriella Pankotai-Bodo; Laurent Brino; Cecile Rochette-Egly
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-06       Impact factor: 11.205

Review 2.  Vitamin A and retinoid signaling: genomic and nongenomic effects.

Authors:  Ziad Al Tanoury; Aleksandr Piskunov; Cécile Rochette-Egly
Journal:  J Lipid Res       Date:  2013-02-24       Impact factor: 5.922

3.  Structure of Liver Receptor Homolog-1 (NR5A2) with PIP3 hormone bound in the ligand binding pocket.

Authors:  Elena P Sablin; Raymond D Blind; Rubatharshini Uthayaruban; Hsiu-Ju Chiu; Ashley M Deacon; Debanu Das; Holly A Ingraham; Robert J Fletterick
Journal:  J Struct Biol       Date:  2015-09-28       Impact factor: 2.867

4.  RAR/RXR binding dynamics distinguish pluripotency from differentiation associated cis-regulatory elements.

Authors:  Amandine Chatagnon; Philippe Veber; Valérie Morin; Justin Bedo; Gérard Triqueneaux; Marie Sémon; Vincent Laudet; Florence d'Alché-Buc; Gérard Benoit
Journal:  Nucleic Acids Res       Date:  2015-04-20       Impact factor: 16.971

5.  Allosteric Regulation in the Ligand Binding Domain of Retinoic Acid Receptorγ.

Authors:  Yassmine Chebaro; Serena Sirigu; Ismail Amal; Régis Lutzing; Roland H Stote; Cécile Rochette-Egly; Natacha Rochel; Annick Dejaegere
Journal:  PLoS One       Date:  2017-01-26       Impact factor: 3.240

6.  Phosphorylation of the retinoic acid receptor alpha induces a mechanical allosteric regulation and changes in internal dynamics.

Authors:  Yassmine Chebaro; Ismail Amal; Natacha Rochel; Cécile Rochette-Egly; Roland H Stote; Annick Dejaegere
Journal:  PLoS Comput Biol       Date:  2013-04-18       Impact factor: 4.475

7.  Evolutionary diversification of retinoic acid receptor ligand-binding pocket structure by molecular tinkering.

Authors:  Juliana Gutierrez-Mazariegos; Eswar Kumar Nadendla; Romain A Studer; Susana Alvarez; Angel R de Lera; Shigehiro Kuraku; William Bourguet; Michael Schubert; Vincent Laudet
Journal:  R Soc Open Sci       Date:  2016-03-16       Impact factor: 2.963

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.